Literature DB >> 7658068

Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection.

L F Xi1, G W Demers, L A Koutsky, N B Kiviat, J Kuypers, D H Watts, K K Holmes, D A Galloway.   

Abstract

Sequence differences in the noncoding region of the human papillomavirus type 16 (HPV-16) genome were displayed using single-stranded conformational polymorphism (SSCP) analysis of polymerase chain reaction (PCR)-amplified material. Two variants accounted for 50%-70% of all HPV-16 variants from 3 cohorts in Seattle. Seventy subjects who were repeatedly HPV-16 DNA-positive over 2-8 4-monthly visits showed an identical SSCP pattern at every visit. Only 10%-20% of the specimens showed evidence of infection by multiple variants when assessed by SSCP. However, cloning and sequencing of the PCR products revealed a substantially higher proportion of specimens with > 1 variant. Sequencing many clones from each specimen confirmed that 1 major variant seemed to predominate over time, whereas minor variants appeared more transient. These results suggest that HPV-16 establishes a persistent infection in which a single variant predominates: coinfection with addition HPV-16 variants results in a minor population of HPV-16 genomes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658068     DOI: 10.1093/infdis/172.3.747

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Human papillomavirus type 16 variants in paired enrollment and follow-up cervical samples: implications for a proper understanding of type-specific persistent infections.

Authors:  Long Fu Xi; Laura A Koutsky; Philip E Castle; Zoe R Edelstein; Ayaka Hulbert; Mark Schiffman; Nancy B Kiviat
Journal:  J Infect Dis       Date:  2010-10-26       Impact factor: 5.226

2.  Applications of polymerase chain reaction-single stranded conformational polymorphism to microbiology.

Authors:  J R Kerr; M D Curran
Journal:  Clin Mol Pathol       Date:  1996-12

3.  Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.

Authors:  T Yamada; M M Manos; J Peto; C E Greer; N Munoz; F X Bosch; C M Wheeler
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization.

Authors:  C M Wheeler; T Yamada; A Hildesheim; S A Jenison
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

5.  Combination treatment with intralesional cidofovir and viral-DNA vaccination cures large cottontail rabbit papillomavirus-induced papillomas and reduces recurrences.

Authors:  N D Christensen; R Han; N M Cladel; M D Pickel
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

6.  Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis.

Authors:  M H Mayrand; F Coutlée; C Hankins; N Lapointe; P Forest; M de Ladurantaye; M Roger
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

7.  Difficulties in estimating the male-to-female sexual transmissibility of human papillomavirus infection.

Authors:  Ali Rowhani-Rahbar; James P Hughes; Laura A Koutsky
Journal:  Sex Transm Dis       Date:  2009-04       Impact factor: 2.830

8.  Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis.

Authors:  Ingeborg Zehbe; Christina Richard; Correne A DeCarlo; Anny Shai; Paul F Lambert; Hava Lichtig; Massimo Tommasino; Levana Sherman
Journal:  Virology       Date:  2008-11-04       Impact factor: 3.616

Review 9.  Human Immunodeficiency Virus and Human Papilloma Virus - why HPV-induced lesions do not spontaneously resolve and why therapeutic vaccination can be successful.

Authors:  Sjoerd H van der Burg; Joel M Palefsky
Journal:  J Transl Med       Date:  2009-12-18       Impact factor: 5.531

10.  Identification of recombinant human papillomavirus type 16 variants.

Authors:  Mingjun Jiang; Long Fu Xi; Zoe R Edelstein; Denise A Galloway; Gary J Olsem; William Chun-Che Lin; Nancy B Kiviat
Journal:  Virology       Date:  2009-09-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.